NVDA_JPM_Healthcare-2026.pdf

1、NVIDIA Healthcare and Life SciencesKimberly Powell,VP of Healthcare and Lifesciences January 12,2026Except for the historical information contained herein,certain matters in this presentation including,but not limited to,statements as to:expectations with respect to the benefits,impact,performance,a

2、nd availability of NVIDIAs products,services and technologies;expectations with respect to NVIDIAs third-party arrangements,including with its collaborators and partners;expectations with respect to technology developments;expectations with respect to AI and related industries;and other statements t

3、hat are not historical facts are forward-looking statements within the meaning of Section 27A of the Securities Act of 1933,as amended,and Section 21E of the Securities Exchange Act of 1934,as amended,which are subject to the“safe harbor”created by those sections based on managements beliefs and ass

4、umptions and on information currently available to management and are subject to risks and uncertainties that could cause results to be materially different than expectations.Important factors that could cause actual results to differ materially include:global economic and political conditions;NVIDI

5、As reliance on third parties to manufacture,assemble,package and test NVIDIAs products;the impact of technological development and competition;development of new products and technologies or enhancements to NVIDIAs existing product and technologies;market acceptance of NVIDIAs products or NVIDIAs pa

6、rtners products;design,manufacturing or software defects;changes in consumer preferences or demands;changes in industry standards and interfaces;unexpected loss of performance of NVIDIAs products or technologies when integrated into systems;and changes in applicable laws and regulations,as well as o